Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL613351 | 0.97 | — | — | |
| Sulfamate SCHEMBL29014386 | 0.85 | SLC6A4 (0.34) | SLC6A4HSD17B10 | |
| SCHEMBL11742875 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL9426341 | 0.78 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL1408201 | 0.78 | — | — | |
| Monoethanolamine SCHEMBL10839687 | 0.78 | TSHR (0.38) | SLC6A4HSD17B10ALDH1A1 | |
| SCHEMBL1888688 | 0.76 | — | — | |
| SCHEMBL11664956 | 0.76 | — | — | |
| SCHEMBL17604 | 0.76 | — | — | |
| SCHEMBL12940281 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329715-A1 | HAIR COMPOSITIONS COMPRISING AT LEAST 50% POLYOL | L'OREAL (FR) | 2024-03-06 | — | — | EP | disclosed |
| US-10328009-B1 | Methods and compositions for improving the durability of color in artificially colored hair | L'OREAL (FR) | 2019-06-25 | — | — | US | disclosed |
| EP-1487419-A2 | FAST DISSOLVING DOSAGE FORMS HAVING REDUCED FRIABILITY | Elan Pharma International Limited (IE) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003080023-A2 | FAST DISSOLVING DOSAGE FORMS HAVING REDUCED FRIABILITY | ELAN PHARMA INTERNATIONAL LIMITED (IE) | 2003-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328009-B1 | Methods and compositions for improving the durability of color in artificially colored hair | TYR, COXFA4L2, OAT | SLC6A4 1584/4885HSD17B10 1609/4885ALDH1A1 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.